| Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: An immunohistochemical study E Núñez, C Benito, MR Pazos, A Barbachano, O Fajardo, S González, ... Synapse 53 (4), 208-213, 2004 | 449 | 2004 |
| Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity J Palazuelos, T Aguado, MR Pazos, B Julien, C Carrasco, E Resel, ... Brain 132 (11), 3152-3164, 2009 | 425 | 2009 |
| Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? J Fernández‐Ruiz, O Sagredo, MR Pazos, C García, R Pertwee, ... British journal of clinical pharmacology 75 (2), 323-333, 2013 | 413 | 2013 |
| Cannabinoid CB2 receptors in human brain inflammation C Benito, RM Tolón, MR Pazos, E Núñez, AI Castillo, J Romero British journal of pharmacology 153 (2), 277-285, 2008 | 365 | 2008 |
| Mechanisms of cannabidiol neuroprotection in hypoxic–ischemic newborn pigs: Role of 5HT1A and CB2 receptors MR Pazos, N Mohammed, H Lafuente, M Santos, E Martínez-Pinilla, ... Neuropharmacology 71, 282-291, 2013 | 238 | 2013 |
| Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington’s disease C Blazquez, A Chiarlone, O Sagredo, T Aguado, MR Pazos, E Resel, ... Brain 134 (1), 119-136, 2011 | 232 | 2011 |
| Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: Relevance for Huntington's disease O Sagredo, S González, I Aroyo, MR Pazos, C Benito, I Lastres‐Becker, ... Glia 57 (11), 1154-1167, 2009 | 211 | 2009 |
| Cannabidiol administration after hypoxia–ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function MR Pazos, V Cinquina, A Gómez, R Layunta, M Santos, ... Neuropharmacology 63 (5), 776-783, 2012 | 176 | 2012 |
| The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages RM Tolón, E Núñez, MR Pazos, C Benito, AI Castillo, JA Martínez-Orgado, ... Brain research 1283, 148-154, 2009 | 166 | 2009 |
| Functional neuroanatomy of the endocannabinoid system MR Pazos, E Núñez, C Benito, RM Tolón, J Romero Pharmacology Biochemistry and Behavior 81 (2), 239-247, 2005 | 165 | 2005 |
| Role of CB2 receptors in neuroprotective effects of cannabinoids J Fernández-Ruiz, MR Pazos, M García-Arencibia, O Sagredo, JA Ramos Molecular and cellular endocrinology 286 (1-2), S91-S96, 2008 | 153 | 2008 |
| Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling E Moreno, C Andradas, M Medrano, MM Caffarel, E Pérez-Gómez, ... Journal of Biological Chemistry 289 (32), 21960-21972, 2014 | 135 | 2014 |
| Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer’s disease A López, N Aparicio, MR Pazos, MT Grande, MA Barreda-Manso, ... Journal of neuroinflammation 15, 1-11, 2018 | 127 | 2018 |
| Neuroprotective effects of phytocannabinoid‐based medicines in experimental models of Huntington's disease O Sagredo, MR Pazos, V Satta, JA Ramos, RG Pertwee, ... Journal of neuroscience research 89 (9), 1509-1518, 2011 | 123 | 2011 |
| Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia-ischemia in newborn pigs H Lafuente, FJ Alvarez, MR Pazos, A Alvarez, MC Rey-Santano, V Mielgo, ... Pediatric research 70 (3), 272-277, 2011 | 115 | 2011 |
| The endocannabinoid system in Huntington's disease MR Pazos, O Sagredo, J Fernandez-Ruiz Current pharmaceutical design 14 (23), 2317-2325, 2008 | 99 | 2008 |
| Role of the endocannabinoid system in Alzheimer's disease: new perspectives MR Pazos, E Nunez, C Benito, RM Tolon, J Romero Life sciences 75 (16), 1907-1915, 2004 | 97 | 2004 |
| The cannabinoid agonist WIN55212 reduces brain damage in an in vivo model of hypoxic-ischemic encephalopathy in newborn rats D Fernández-López, MR Pazos, RM Tolon, M Moro, J Romero, ... Pediatric research 62 (3), 255-260, 2007 | 91 | 2007 |
| The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 … C Del Río, C Navarrete, JA Collado, ML Bellido, M Gómez-Cañas, ... Scientific reports 6 (1), 21703, 2016 | 86 | 2016 |
| The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of … S Valdeolivas, MR Pazos, T Bisogno, F Piscitelli, FA Iannotti, M Allara, ... Cell death & disease 4 (10), e862-e862, 2013 | 86 | 2013 |
Javier Fernández-RuizProfesor de Bioquímica, Universidad ComplutenseVerified email at ucm.es
